IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 23-28

  McRae, Bradford L ^a,b   Beilfuss, Beth A ^a   Van Seventer, Gijs A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BASF Bioresearch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6;

ARTICLE; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033961721     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.23     Document Type: Article

References (30)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Friedman, R. M. 1990. Interferons. In Immunophysiology. J. J. Oppenheim and E. M. Shevach, eds. Oxford University Press, Oxford, U.K., p. 194.
3. Biron, C. A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.
4. + T helper I cell differentiation in vitro by inhibiting dendritic cell production of IL-12. J. Immunol. 160:4298.
5. Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin 12. J. Leukocyte Biol. 59:505.
6. Trinchieri, G. 1998. Interleukin 12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:243.
7. Koch, F., U. Stanzl, P. Jeenewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
8. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 inhibits human lymphocyte interferon γ-producing by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
9. Bright, J. J., and S. Sriram. 1998. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161:1772.
10. Gerrard, T. L., C. H. Jurgensen, and A. S. Fauci. 1983. Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretion. Cell. Immunol. 82:394.
11. + T cells, J. Exp. Med. 180:2125.
12. Van Kooten, C., and J. Banchereau. 1997 Functions of CD40 on B cells, dendritic cells and other cells. Curr .Opin. Immunol. 9:330.
13. Cousens L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634.
14. McRae, B., L. J. Picker, and G. A. van Seventer. 1997. Human recombinant IFN-β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors. Eur. J. Immunol. 27:2650.
15. Pollice, P. F., J. Hsu, D. G. Hicks, S. Bukata, R. N. Rosier, P. R. Reynolds, J. E. Puzas, and R. J. O'Keefe. 1998. Interleukin-10 inhibits cytokine synthesis in monocytes stimulated by titanium particles: evidence of an anti-inflammatory regulatory pathway. J. Orthop. Res. 16:697.
16. Silvennoinen O., J. N. Ihle, J. Schlessinger, and D. E. Levy. 1993. Interferoninduced nuclear signalling by Jak protein tyrosine kinases. Nature 366:583 .
17. Wright, S. D., R. A Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14 serves as the cellular receptor for complexes of lipopolysaccharides with lipopolysaccharide binding protein. Science 249:1431.
18. Kirschning, C. J., H. Wesche, A. T. Merrill, and M. Rothe. 1998. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med 188:2091.
19. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
20. Hanissian, S. H., and R. S. Geha. 1997. jak3 Is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379.
21. Karras, J. G., Z. Wang, L. Huo, D. A. Frank, and T. L. Rothstein. 1997. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol. 159:4350.
22. Deng, W., Y. Ohmori, and T. A. Hamilton. 1996. LPS does not directly induce STAT activity in mouse macrophages. Cell. Immunol. 170:20.
23. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:5258.
24. Yoshimoto, T., Nagase, H., Ishida, T., Inoue, J., and Nariuchi, H. 1997. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-κB. Eur. J. Immunol. 3461.
25. Lin, S. C., H. H. Wortis, and J. Stavnezer. 1998. The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobin switching to immunoglobin G1 is explained by differential induction of NF-κB/Rel proteins. Mol. Cell. Biol. 18: 5523.
26. Lopez-Collazo, E., S. Hortelano, A. Rojas, and L. Bosca. 1998. Triggering of peritoneal macrophages with IFN-αβ attenuates the expression of inducible nitric oxide synthase through a decrease in NF-κB activation. J. Immunol. 160: 2889.
27. Gribaudo, G., S. Ravaglia, M. Gaboli, M. Gariglio, R. Cavallo, and S. Landolfo. 1995. Interferon α inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-κB activity. Virology 211:251.
28. Chatterjee, M., S. Agrawal, and S. S. Agarwal. 1996. Differential effect of IFN-α and IFN-γ on phosphorylation of p65 and p50 (rel) in the K562 cell line: implications for altered interaction with RXR β. Cytokine 8:357.
29. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.
30. IFN-β Multiple Sclerosis Study group. 1993. Interferon-β-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:5.